“…All these conditions lead to a decrease in protein quality control and make UPS a suitable target for cancer therapy [ 218 , 219 ]. Accordingly, a number of proteasome based-strategies have been proposed, spanning from (i) inhibition of proteasome proteolytic activity, (ii) modulation of the abundance of proteasome regulatory particles (i.e., 19S or PA28) and of their interaction with the 20S to (iii) modulation of the activity of enzymes involved in proteasome subunit post-translational modifications and (iv) interference with transport of natural low-molecular-weight proteasome activators (e.g., spermine) [ 62 , 226 , 227 , 228 , 229 , 230 , 231 , 232 ]. Additionally, a series of strategies targeting the ubiquitination cascade have been studied.…”